CLINICAL_TRIALS
trial_result
· 2012-10-16
Clinical Trial Update: Efficacy and Safety of Intravitreal Bevacizumab for Threshold ROP. [NA]
Summary
This clinical trial update reports on the efficacy and safety of intravitreal bevacizumab for threshold retinopathy of prematurity.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sivakami A Pai | Conditions: Stage 2+ or Stage 3+ Retinopathy of Prematurity in Zone I or Zone II. | NA | Status: UNKNOWN